U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07323511) titled 'Abuse Liability for Eight Electronic Nicotine Products' on Dec. 22, 2025.
Brief Summary: This will be a randomized, open-label, 8-way crossover, single-site study designed to evaluate elements of abuse liability (AL), including subjective effects and physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy adult smokers of combustible cigarettes and dual users of cigarettes and ENDS products.
Study Start Date: Feb. 15
Study Type: INTE...